Skip to main content
Profound Medical Corp. logo

Profound Medical Corp. — Investor Relations & Filings

Ticker · PROF TSX Manufacturing
Filings indexed 659 across all filing types
Latest filing 2020-03-19 Regulatory Filings
Country CA Canada
Listing TSX PROF

About Profound Medical Corp.

https://profoundmedical.com/

Profound Medical Corp. is a commercial-stage medical technology company specializing in incision-free ablative therapies. Its core product is TULSA-PRO®, a therapeutic platform designed for the treatment of localized prostate cancer, radiorecurrent prostate cancer, and benign prostatic hyperplasia (BPH). TULSA-PRO utilizes a robotically controlled, transurethral ultrasound ablation procedure guided by real-time Magnetic Resonance (MR) imaging. This system employs closed-loop temperature feedback to ensure precise and customizable tissue ablation, prioritizing patient safety and minimizing complications. The technology merges MR imaging, thermal ultrasound, and robotics to offer a durable and accurate treatment delivery method.

Recent filings

Filing Released Lang Actions
Notice of the meeting and record date - English.pdf
Regulatory Filings Classification · 95% confidence The document is a confirmation notice from TSX Trust Company regarding the record and meeting dates for the upcoming Annual Meeting of Security Holders of Profound Medical Corp. It includes details such as the meeting date, record date for notice and voting, and information about proxy materials. The document is short (2318 characters) and serves as an announcement or confirmation of meeting logistics rather than the meeting materials themselves or voting results. It does not contain financial data, management discussion, or voting outcomes. Therefore, it fits best as a Regulatory Filing (RNS) since it is a general regulatory announcement about meeting dates and proxy material distribution, not the actual AGM materials or voting results.
2020-03-19 English
News release - English.pdf
Regulatory Filings
2020-03-03 English
Annual information form - English.pdf
Annual Report Classification · 100% confidence The document is titled 'FORM 10-K' and explicitly states it is an 'ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019.' It includes detailed sections typical of a 10-K filing such as Business, Risk Factors, Legal Proceedings, Management's Discussion and Analysis, Financial Statements, and Executive Compensation. The length of the document (15,000 characters) and the presence of substantive financial and operational information confirm it is the full annual report, not just an announcement or summary. Therefore, the document is classified as an Annual Report (10-K). FY 2019
2020-03-03 English
Annual information form - English.pdf
Annual Report Classification · 95% confidence The document is titled 'ANNUAL INFORMATION FORM FOR THE YEAR ENDED DECEMBER 31, 2019' and contains detailed sections typical of an annual information form, including corporate structure, business development, risk factors, acquisitions, intellectual property, dividends, capital structure, directors and officers, legal proceedings, audit committee information, and more. It references financial information prepared according to IFRS and is dated as of the last day of the fiscal year. The length is substantial (15,000 characters), indicating it is a full report rather than a brief announcement. The content and structure align with an Annual Report or Annual Information Form, which is a comprehensive yearly report covering company activity and financial performance. Therefore, the appropriate classification is Annual Report (10-K). FY 2019
2020-03-03 English
52-109F1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a FORM 52-109F1 Certification of Annual Filings Full Certificate signed by the CEO. It certifies the review and fair presentation of the annual filings including the AIF, annual financial statements, and annual MD&A for the financial year ended December 31, 2019. The document focuses on the certification of disclosure controls and internal controls over financial reporting. It does not contain actual financial statements or substantive financial data but is an attestation by the CEO regarding the annual filings. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS) rather than the actual annual report (10-K) or other financial reports. The document length is 4521 characters, which is relatively short and consistent with a certification letter rather than a full report. Therefore, the appropriate classification is Regulatory Filings (RNS).
2020-03-03 English
52-109F1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109F1 Certification of Annual Filings Full Certificate signed by the CFO. It certifies the review and fair presentation of the annual filings including the AIF, annual financial statements, and annual MD&A for the fiscal year ended December 31, 2019. The document focuses on the officer's certification of the accuracy and completeness of the annual filings and the effectiveness of disclosure controls and internal controls over financial reporting. It does not contain the actual annual report or financial statements but is a formal attestation related to those filings. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS) rather than the actual annual report (10-K). The document length is 4527 characters, which is relatively short and consistent with a certification letter rather than a full report. Therefore, the appropriate classification is Regulatory Filings (RNS).
2020-03-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.